Serena Fortuna

502 total citations
8 papers, 391 citations indexed

About

Serena Fortuna is a scholar working on Infectious Diseases, Pediatrics, Perinatology and Child Health and Epidemiology. According to data from OpenAlex, Serena Fortuna has authored 8 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 3 papers in Pediatrics, Perinatology and Child Health and 3 papers in Epidemiology. Recurrent topics in Serena Fortuna's work include HIV/AIDS drug development and treatment (4 papers), Pharmacological Effects and Toxicity Studies (3 papers) and HIV Research and Treatment (2 papers). Serena Fortuna is often cited by papers focused on HIV/AIDS drug development and treatment (4 papers), Pharmacological Effects and Toxicity Studies (3 papers) and HIV Research and Treatment (2 papers). Serena Fortuna collaborates with scholars based in Italy, Japan and Canada. Serena Fortuna's co-authors include Pierluigi Navarra, Enzo Ragazzoni∘, Annalisa Tortora, Antonio Gasbarrini, Anna Rita Bentivoglio, Francesco Bove, Stefano Marconi, Maria Assunta Zocco, Maurizio Gabrielli and Alfonso Fasano and has published in prestigious journals such as Intensive Care Medicine, Movement Disorders and Therapeutic Drug Monitoring.

In The Last Decade

Serena Fortuna

8 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Serena Fortuna Italy	7	188	99	80	77	61	8	391
Chuhong Tan China	9	63 0.3×	703 7.1×	56 0.7×	102 1.3×	10 0.2×	13	881
Xiuli Zeng China	9	70 0.4×	659 6.7×	49 0.6×	95 1.2×	7 0.1×	13	844
Julie Ann Kemp Brazil	11	28 0.1×	263 2.7×	8 0.1×	18 0.2×	40 0.7×	31	552
Matthew Q. Bromer United States	9	50 0.3×	20 0.2×	57 0.7×	8 0.1×	22 0.4×	14	644
Kristine C. Willett United States	12	16 0.1×	40 0.4×	6 0.1×	20 0.3×	41 0.7×	23	316
Cindy James Canada	8	16 0.1×	92 0.9×	5 0.1×	64 0.8×	73 1.2×	9	420
Ryutaro Arita Japan	11	19 0.1×	57 0.6×	7 0.1×	12 0.2×	30 0.5×	57	392
Rajan Gadhia United States	8	124 0.7×	83 0.8×	3 0.0×	58 0.8×	9 0.1×	33	487
Risto Roine Finland	11	35 0.2×	56 0.6×	12 0.1×	7 0.1×	47 0.8×	19	371
Daniel Y. Li United States	6	14 0.1×	457 4.6×	8 0.1×	72 0.9×	23 0.4×	6	677

Countries citing papers authored by Serena Fortuna

Since Specialization

Citations

This map shows the geographic impact of Serena Fortuna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serena Fortuna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serena Fortuna more than expected).

Fields of papers citing papers by Serena Fortuna

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serena Fortuna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serena Fortuna. The network helps show where Serena Fortuna may publish in the future.

Co-authorship network of co-authors of Serena Fortuna

This figure shows the co-authorship network connecting the top 25 collaborators of Serena Fortuna. A scholar is included among the top collaborators of Serena Fortuna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serena Fortuna. Serena Fortuna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Pascale, Gennaro De, Serena Fortuna, Mario Tumbarello, et al.. (2014). Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration. Intensive Care Medicine. 41(1). 103–110. 41 indexed citations

Fasano, Alfonso, Francesco Bove, Maurizio Gabrielli, et al.. (2014). Liquid Melevodopa Versus Standard Levodopa in Patients With Parkinson Disease and Small Intestinal Bacterial Overgrowth. Clinical Neuropharmacology. 37(4). 91–95. 14 indexed citations

Gagliardini, Roberta, Massimiliano Fabbiani, Serena Fortuna, et al.. (2014). Pharmacokinetics of etravirine in HIV-infected patients concomitantly treated with rifampin for tuberculosis. Infection. 42(4). 775–8. 5 indexed citations

Fortuna, Serena, Enzo Ragazzoni∘, Lucia Lisi, et al.. (2013). Validation of an UPLC-MS/MS Method for Quantitative Analysis of Raltegravir in Human Plasma Samples. Therapeutic Drug Monitoring. 35(2). 258–263. 9 indexed citations

Fabbiani, Massimiliano, Annalisa Mondi, Manuela Colafigli, et al.. (2013). Safety and efficacy of treatment switch to raltegravir plus tenofovir/emtricitabine or abacavir/lamivudine in patients with optimal virological control: 48-week results from a randomized pilot study (Raltegravir Switch for Toxicity or Adverse Events, RASTA Study). Scandinavian Journal of Infectious Diseases. 46(1). 34–45. 21 indexed citations

Fortuna, Serena, Massimiliano Fabbiani, Enzo Ragazzoni∘, et al.. (2013). Variability of Raltegravir Plasma Levels in the Clinical Setting. Pharmacology. 92(1-2). 43–48. 7 indexed citations

Fasano, Alfonso, Francesco Bove, Maurizio Gabrielli, et al.. (2013). The role of small intestinal bacterial overgrowth in Parkinson's disease. Movement Disorders. 28(9). 1241–1249. 268 indexed citations

Fortuna, Serena, Gennaro De Pascale, Enzo Ragazzoni∘, Massimo Antonelli, & Pierluigi Navarra. (2013). Validation of a new HPLC‐UV method for determination of the antibiotic linezolid in human plasma and in bronchoalveolar lavage. Biomedical Chromatography. 27(11). 1489–1496. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact